CD8A and cancer: Independent studies have shown that M7824 depletes soluble TGF-ꞵ and increases T-cell trafficking into tumor sites along with antigen-specific CD8+ T-cell mediated cytolytic activity, but it also enforces changes in the microenvironment in favor of the immune system to potentially increase the efficacy of cancer vaccines 148, 149.